GAO Report Renews Debate Over Device Price Confidentiality
This article was originally published in The Pink Sheet Daily
Executive Summary
Hospitals, group purchasing organizations and other health care stakeholders want Congress to do away with pricing confidentiality clauses in purchase contracts for implantable devices, but industry wants to maintain its ability to keep device prices secret.
You may also be interested in...
Implantable Device Pricing, Utilization Are Under GAO's Microscope
The Government Accountability Office is investigating the pricing and utilization of implantable medical devices at the request of Senate Finance Committee Chairman Max Baucus, D-Mont
Physicians Show Willingness To Consider Cost When Choosing Devices
Surgeons need better tools and more incentives to help them pay more attention to cost as they choose the devices they use, according to speakers at a recent conference on value-based purchasing
Mandatory Disclosure Of Device Pricing Would Raise Costs – Industry Study
A pending Senate bill that calls for mandatory disclosure of prices paid by hospitals for implantable medical devices would most likely lead to higher prices, contrary to its original intent, according to a 1study released Feb. 19